ask="1.00"
ask_size="2000"
average_daily_volume="N/A"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="+0.02"
change_from_200_day_moving_average="0.27"
change_from_50_day_moving_average="0.27"
change_from_52_week_high="-0.18"
change_From_52_week_low="0.00"
change_in_percent="+8.00%"
close="0.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.45"
high_52_weeks="0.45"
last_trade_date="1/30/2017"
last_trade_price="0.27"
last_trade_size="2000"
last_trade_time="1:16pm"
low="0.27"
low_52_weeks="0.27"
market_capitalization="N/A"
moving_average_200_day="0.00"
moving_average_50_day="0.00"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="N/A"
open="0.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+inf%"
percent_change_from_50_day_moving_average="+inf%"
percent_change_from_52_week_high="-40.00%"
percent_change_from_52_week_low="+0.00%"
previous_close="0.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="EYEGW"
volume="6400"
weeks_range_52="0.27 - 0.45"
